Creative Planning’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41M Buy
86,571
+4,614
+6% +$2.32M 0.03% 254
2025
Q4
$38.3M Buy
81,957
+17,599
+27% +$8.17M 0.03% 247
2025
Q3
$27.4M Buy
64,358
+4,355
+7% +$1.69M 0.02% 294
2025
Q2
$23M Buy
60,003
+6,122
+11% +$2.21M 0.02% 311
2025
Q1
$18.6M Buy
53,881
+6,378
+13% +$2.05M 0.02% 344
2024
Q4
$14.3M Sell
47,503
-86
-0.2% -$30.1K 0.01% 362
2024
Q3
$19.3M Buy
47,589
+13,015
+38% +$4.77M 0.02% 292
2024
Q2
$11.1M Buy
34,574
+2,333
+7% +$758K 0.01% 388
2024
Q1
$10.8M Buy
32,241
+3,372
+12% +$1.03M 0.01% 388
2023
Q4
$7.81M Sell
28,869
-7,404
-20% -$1.83M 0.01% 443
2023
Q3
$8.92M Buy
36,273
+7,350
+25% +$2.01M 0.01% 383
2023
Q2
$8.78M Buy
28,923
+1,324
+5% +$368K 0.01% 379
2023
Q1
$7.28M Buy
27,599
+1,087
+4% +$276K 0.01% 406
2022
Q4
$6.36M Buy
26,512
+2,900
+12% +$650K 0.01% 427
2022
Q3
$4.34M Sell
23,612
-513
-2% -$102K 0.01% 468
2022
Q2
$4.05M Buy
24,125
+1,612
+7% +$346K 0.01% 510
2022
Q1
$5.64M Buy
22,513
+9,041
+67% +$2.27M 0.01% 425
2021
Q4
$3.46M Buy
13,472
+47
+0.4% +$11.5K 0.01% 521
2021
Q3
$3.26M Buy
13,425
+119
+0.9% +$29.1K 0.01% 538
2021
Q2
$2.75M Buy
13,306
+1,413
+12% +$288K ﹤0.01% 568
2021
Q1
$2.24M Buy
11,893
+266
+2% +$46.9K ﹤0.01% 679
2020
Q4
$1.91M Sell
11,627
-294
-2% -$43K ﹤0.01% 686
2020
Q3
$1.49M Buy
11,921
+471
+4% +$58.3K ﹤0.01% 670
2020
Q2
$1.11M Buy
11,450
+223
+2% +$23.2K ﹤0.01% 712
2020
Q1
$1.01M Buy
11,227
+552
+5% +$71.5K ﹤0.01% 645
2019
Q4
$1.58M Buy
10,675
+1,926
+22% +$259K ﹤0.01% 599
2019
Q3
$1.05M Sell
8,749
-40
-0.5% -$5.17K ﹤0.01% 729
2019
Q2
$1.19M Buy
8,789
+411
+5% +$52K ﹤0.01% 696
2019
Q1
$1.09M Buy
8,378
+238
+3% +$32K ﹤0.01% 699
2018
Q4
$1.01M Sell
8,140
-728
-8% -$97.7K ﹤0.01% 660
2018
Q3
$1.23M Buy
8,868
+927
+12% +$115K ﹤0.01% 671
2018
Q2
$815K Buy
7,941
+9
+0.1% +$911 ﹤0.01% 855
2018
Q1
$769K Sell
7,932
-2,843
-26% -$276K ﹤0.01% 872
2017
Q4
$946K Sell
10,775
-728
-6% -$58.5K ﹤0.01% 762
2017
Q3
$916K Buy
11,503
+83
+0.7% +$6.67K ﹤0.01% 760
2017
Q2
$996K Sell
11,420
-23
-0.2% -$1.95K 0.01% 695
2017
Q1
$1.02M Sell
11,443
-907
-7% -$75.6K 0.01% 664
2016
Q4
$914K Buy
12,350
+1,323
+12% +$99.1K 0.01% 661
2016
Q3
$834K Buy
11,027
+549
+5% +$42K 0.01% 666
2016
Q2
$807K Buy
10,478
+2,917
+39% +$230K 0.01% 580
2016
Q1
$590K Sell
7,561
-1,008
-12% -$70.4K ﹤0.01% 686
2015
Q4
$580K Buy
8,569
+1,096
+15% +$76.5K ﹤0.01% 693
2015
Q3
$578K Sell
7,473
-5,217
-41% -$462K 0.01% 680
2015
Q2
$1.15M Buy
12,690
+456
+4% +$36.5K 0.01% 428
2015
Q1
$920K Sell
12,234
-41
-0.3% -$2.94K 0.01% 497
2014
Q4
$901K Sell
12,275
-3,689
-23% -$259K 0.01% 486
2014
Q3
$1.13M Buy
15,964
+387
+2% +$25.6K 0.01% 361
2014
Q2
$878K Sell
15,577
-5,242
-25% -$277K 0.01% 431
2014
Q1
$1.09M Buy
20,819
+899
+5% +$44.7K 0.02% 340
2013
Q4
$950K Buy
19,920
+9,010
+83% +$416K 0.02% 321
2013
Q3
$466K Sell
10,910
-390
-3% -$15.2K 0.01% 466
2013
Q2
$407K Buy
+11,300
New +$437K 0.01% 460

Other funds holding HCA

Creative Planning's HCA Position: Q1 2026 in Review

Creative Planning increased its HCA Healthcare (HCA) stake by 5.6% in Q1 2026, buying an estimated $2.32M and bringing the position to 86,571 shares worth $41M. The position accounts for 0.03% of the portfolio, ranked #254.

Creative Planning first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Creative Planning held 86,571 shares of HCA Healthcare worth $41M as of Q1 2026.
  • Creative Planning bought 4,614 HCA Healthcare shares in Q1 2026, an estimated $2.32M.
  • HCA Healthcare made up 0.03% of Creative Planning's portfolio in Q1 2026, its #254 holding.
  • Creative Planning first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.